M&A Deal Summary

Calculus Capital Acquires C4X Discovery Holdings

On September 6, 2016, private equity firm Calculus Capital acquired life science company C4X Discovery Holdings for 3M GBP

Acquisition Highlights
  • This is Calculus Capital’s 7th transaction in the Life Science sector.
  • This is Calculus Capital’s largest (disclosed) transaction.
  • This is Calculus Capital’s 18th transaction in the United Kingdom.

M&A Deal Summary

Date 2016-09-06
Target C4X Discovery Holdings
Sector Life Science
Buyer(s) Calculus Capital
Deal Type Secondary Buyout
Deal Value 3M GBP

Target

C4X Discovery Holdings

Manchester, United Kingdom
C4X Discovery Holdings plc is a provider of pre-clinical drug design and development for use in the treatment of a wide range of diseases and medical conditions.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

DESCRIPTION

Calculus Capital is a UK-based investment group focused on fast-growth companies. Calculus Capital is sector agnostic and looks to commit £2 to £5 million per investment. Calculus Capital is based in London.


DEAL STATS #
Overall 19 of 44
Sector (Life Science) 7 of 11
Type (Secondary Buyout) 1 of 2
Country (United Kingdom) 18 of 42
Year (2016) 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-07-14 genedrive

Manchester, United Kingdom

genedrive is a commercial stage personalised medicine and biotechnology company developing innovative diagnostics and biomarkers alongside providing contract research services to drug development companies. genedrive was founded in 2000 and is based in Manchester, the United Kingdom.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-10-10 Human Race Partnership

Chessington, United Kingdom

Human Race Partnership Ltd. is a mass participation sports company that owns and operates events including running, cycling, swimming and triathlon.

Sell -